Showing 2181-2190 of 7668 results for "".
- ‘SUNucate’ Laws Do Increase Interest in Sun Protection, Youth Sunscreen Usehttps://practicaldermatology.com/news/sunucate-laws-do-increase-interest-in-sun-protection-youth-sunscreen-use/2461998/States that enacted SUNUCATE laws permitting children to carry and apply sunscreen at school experienced an increased interest in sun protection and a higher rate of sunscreen use among adolescents, according to new research by a University of Massachusetts Amherst resource economist. Brandyn Chu…
- New Surgical Technique Offers Hope to Folliculitis Decalvans Patientshttps://practicaldermatology.com/news/experimental-surgical-technique-offers-hope-to-folliculitis-decalvans-patients/2461997/The lack of long-term solutions in the challenging treatment of folliculitis decalvans (FD) led Sanusi Umar MD, and colleagues from Dr. U Hair and Skin Clinic to develop and patent a novel device that holds potential for sustained FD remission. Dubbed the Athena Suture Guards, the device is a high…
- CeraVe Launches New #ClearItUpLikeADerm Campaignhttps://practicaldermatology.com/news/cerave-launches-new-clearituplikeaderm-campaign/2461996/CeraVe is launching its new Clear It Up Like a Derm campaign to educate consumers on preventing and treating acne. With the help of Drs. Muneeb Shah, Mamina Turegano and Evan A. Rieder, as well as TikTok's Charli D'Amelio (@charlidamelio) and Zach King (@zachking), the CeraVe #ClearItUpLikeADerm …
- Cetaphil Takes on Aging Skin with New Skincare Linehttps://practicaldermatology.com/news/cetaphil-takes-on-aging-skin-with-new-skincare-line/2461995/Galderma is rolling out Cetaphil Healthy Renew, its first-ever healthy aging skincare line. "Aging skin is a particular point of frustration for my sensitive skin patients due to increased risks of irritation and an already compromised skin barrier,” says Cetaphil partner Dendy Engleman, MD Direc…
- Hillstream Enters Into an Exclusive Option Agreement to Acquire a Clinical Stage Asset for Chronic Pruritishttps://practicaldermatology.com/news/hillstream-enters-into-an-exclusive-option-agreement-to-acquire-a-clinical-stage-asset-for-chronic-pruritis/2461994/Hillstream BioPharma, Inc. is set to acquire AV104 for chronic pruritis. AV104 has a dual mechanism of action by affecting multiple receptors, known to suppress chronic, debilitating pruritis. The Company intends to first seek approval in an orphan disease for the treatment of moderate to severe c…
- ABMS Announces Class of 2023-2024 Visiting Scholarshttps://practicaldermatology.com/news/abms-announces-class-of-2023-2024-visiting-scholars/2461993/Gillian Heinecke, MD, an assistant clinical professor at SSM Health/Saint Louis University in St. Louis, Mo. is the American Board of Dermatology’s 2023-2024 Visiting Scholar. The American Board of Medical Specialties (ABMS) selected thirteen outstanding individuals to participate in its 2023-2024…
- Biosimilar News: Samsung Bioepis, Sandoz to Develop SB17, a Proposed Stelara Biosimilar to Stelarahttps://practicaldermatology.com/news/biosimilar-news-samsung-bioepis-sandoz-to-develop-sb17-a-proposed-stelara-biosimilar-to-stelara/2461991/Samsung Bioepis Co., Ltd. has entered into a commercialization agreement with Sandoz for SB17, a proposed biosimilar to Stelara (ustekinumab). Samsung Bioepis will be responsible for development, regulatory registration and manufacture and supply of the product in the United States (US), Canada, …
- Study Sheds Light on Why Wounds Heal Poorly in People With Diabeteshttps://practicaldermatology.com/news/study-sheds-light-on-why-wounds-heal-poorly-in-people-with-diabetes/2461989/When exosomes are defective in diabetic patients, they can drive inflammation and impair healing of wounds, according to a new Nano Today study led by University of Pittsburgh and UPMC researchers. In chronic wounds of diabetes patients, these faulty exosomes can’t deliver vital information to cel…
- ICYMI: Vaseline, CVS Partner to Bridge the Gap of Skin Care Inequities in People of Colorhttps://practicaldermatology.com/news/icymi-vaseline-cvs-partner-to-bridge-the-gap-of-skin-care-inequities-in-people-of-color/2461988/Vaseline’s recent Train the Trainer webinar helped educate CVS field leaders on the skin care inequities that exist for Black and Brown populations as part of the brand’s ongoing partnership with CVS Health. During the webcast, Boston area-based dermatologist Uchenna Okereke, MD, MSc, introduce…
- Interim INTEGUMENT-OLE Results: Arcutis’ Roflumilast Cream 0.15% Performs Well in ADhttps://practicaldermatology.com/news/arcutis-roflumilast-cream-015-performs-well-in-ad/2461987/Roflumilast cream 0.15% showed durable and improved efficacy over time and a favorable safety profile in mild to moderate Atopic Dermatitis (AD), according to interim results from the INTEGUMENT-OLE long-term open-label study. Arcutis intends to submit a supplemental New Drug Application (sNDA) la…